These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1698987

  • 21. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
    Daca A, Czuszyńska Z, Smoleńska Z, Zdrojewski Z, Witkowski JM, Bryl E.
    Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
    [Abstract] [Full Text] [Related]

  • 22. Urinary T cells in active lupus nephritis show an effector memory phenotype.
    Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.
    Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
    [Abstract] [Full Text] [Related]

  • 23. T cell subset composition in remission phase of systemic connective tissue diseases.
    Markeljević J, Marusić M, Uzarević B, Petrovecki M, Trutin-Ostović K, Cikes N, Batinić D, Babic-Naglic D, Horvat Z.
    J Clin Lab Immunol; 1991 May; 35(1):33-9. PubMed ID: 1668288
    [Abstract] [Full Text] [Related]

  • 24. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Niewiadomska H, Robak T, Bartkowiak J, Błoński JZ, Woźniacka A, Pomorski L, Sysa-Jedrezejowska A.
    Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
    [Abstract] [Full Text] [Related]

  • 25. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A, Morimoto S, Nakiri Y, Suzuki J, Kaneko H, Tokano Y, Tsuda H, Takasaki Y, Hashimoto H.
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [Abstract] [Full Text] [Related]

  • 26. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF.
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [Abstract] [Full Text] [Related]

  • 27. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT.
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [Abstract] [Full Text] [Related]

  • 28. 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells.
    Tsuchiya N, Mitamura T, Goto M, Moroi Y, Kinoshita M, Yokohari R, Miyamoto T.
    J Rheumatol; 1988 Jun; 15(6):946-51. PubMed ID: 3262161
    [Abstract] [Full Text] [Related]

  • 29. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N.
    Arthritis Res Ther; 2006 Jun; 8(3):R62. PubMed ID: 16563187
    [Abstract] [Full Text] [Related]

  • 30. Increased Fas and Bcl-2 expression on peripheral mononuclear cells from patients with active juvenile-onset systemic lupus erythematosus.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    J Rheumatol; 2007 Jul; 34(7):1580-4. PubMed ID: 17516614
    [Abstract] [Full Text] [Related]

  • 31. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y, Ogaki M, Abe K, Takeuchi K, Ando S, Tokano Y, Kobayashi S, Sekigawa I, Tsuda H, Hashimoto H.
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Regulatory T cells in patients with systemic lupus erythematosus.
    Alvarado-Sánchez B, Hernández-Castro B, Portales-Pérez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, González-Amaro R.
    J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
    [Abstract] [Full Text] [Related]

  • 34. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS, Van Noordin S, Krausz T, Davies KA.
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [Abstract] [Full Text] [Related]

  • 35. Selective loss of the CD4+ inducers of suppressor T cell subsets (2H4+) in active systemic lupus erythematosus.
    Raziuddin S, Nur MA, Alwabel AA.
    J Rheumatol; 1989 Oct; 16(10):1315-9. PubMed ID: 2530345
    [Abstract] [Full Text] [Related]

  • 36. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y, Lu Q.
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [Abstract] [Full Text] [Related]

  • 37. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C.
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [Abstract] [Full Text] [Related]

  • 38. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H, Xu J, Ji X, Yang X, Sun K, Liu X, Shen Y.
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [Abstract] [Full Text] [Related]

  • 39. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
    Habib HM, Taher TE, Isenberg DA, Mageed RA.
    Scand J Rheumatol; 2009 Jun; 38(2):112-20. PubMed ID: 19110660
    [Abstract] [Full Text] [Related]

  • 40. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK, Lit LC, Tam LS, Li EK, Lam CW.
    Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.